BiotechTube
Home/ReAlta Life Sciences/Howard Berman, Ph.D.
HB

Howard Berman, Ph.D.

Chief Executive Officer

ReAlta Life Sciences

Therapeutic Areas

Neonatal NeurologyInflammatory Diseases

ReAlta Life Sciences Pipeline

DrugIndicationPhase
Pegtarazimod (RLS-0071)Neonatal Hypoxic-Ischemic Encephalopathy (HIE)Phase 2

Leadership Team at ReAlta Life Sciences

KM
Kia Motesharei, Ph.D.
President & Chief Operating Officer
View full ReAlta Life Sciences profile